Mass spectrometric analysis of neuropeptidergic systems in the human pituitary and cerebrospinal fluid

by D. M. Desiderio (Memphis, TN, USA)

3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication

by T. Niwa (Nagoya, Japan)

Gas chromatographic-mass spectrometric analysis of erythrocyte 3-deoxyglucosone in hemodialysis patients

by S. Tsukushi, K. Shimokata and T. Niwa (Nagoya, Japan)

Application of delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of sphingolipids in tissues from sphingolipidosis patients

by T. Fujiwaki and S. Yamaguchi (Shimane, Japan), K. Sukegawa (Gifu, Japan) and T. Taketomi (Nagano, Japan)

Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring

by K. Igarashi, Y. Sugiyama, F. Kasuya and K. Saiki (Kobe, Japan) and T. Yamakawa and S.Ohata   (Hiroshima, Japan)

Oxidation of glyceropholipids from biological membranes by reactive oxygen species: liquid chromatographic-mass spectrometric analysis of eicosanoid products

by R. C. Murphy, N. Khaselev, T. Nakamura and L. M. Hall (Denver, CO, USA)

Simultaneous assay of prostaglandins and thromboxane in the cerebrospinal fluid by gas chromatography-mass spectrometry-selected ion monitoring

by T. Obata, T. Nagakura, H. Maeda, K. Yamashita and K. Maekawa (Tokyo, Japan)

Effect of sports activity on carnitine metabolism. Measurement of free carnitin,  γ-butyrobetaine and acylcarnitines by tandem mass spectrometry

by F. Inoue, N. Terada, H. Nakajima, M. Okochi, N. Kodo, Z. Kizaki, A. Kinugasa and T. Sawada (Kyoto, Japan)

Measurement of carnitine precursors,  ε-trimethyllysine and  γ-butryrobetaine in human serum by tandem mass spectrometry

by N. Terada, F. Inoue, M. Okochi, H. Nakajima, Z. Kizaki, A. Kinugasa and T. Sawada (Kyoto, Japan)

Modifications in electrospray tandem mass spectrometry for a  neonatal-screening pilot study in Japan

by Y. Shigematsu, I. Hata, Y. Kikawa, M. Mayumi, Y. Tanaka, M. Sudo and N. Kado (Fukui, Japan)

Screening for fatty acid beta oxidation disorders. Acylglycine analysis by electron impact ionization gas chromatography-mass spectrometry

by M. Kimura and S. Yamaguchi (Shimane, Japan)

Gas chromatographic-mass spectrometric analysis of urinary sugar and sugar alcohols during pregnancy

by M. Tetsuo (Nagasaki, Japan), C. Zhang, H. Matsumoto and I. Matsumoto (Kanazawa, Japan) 

Determination of glutathionyl hemoglobin in hemodialysis patients using electrospray ionization liquid chromatography-mass spectrometry

by C. Naito, M. Kajita and T. Niwa (Nagoya, Japan)

Establishment of a combined strategy of genetic and mass spectrometric analyses for characterizing hemoglobin mutations. An example of Hb Hoshida (β43Glu→Gln)

by R. Kaneko, Y. Wada, M. Hisada, H. Naoki and T. Matsuo (Osaka, Japan)

Mass spectrometric study on the protein chemical modification of uremic patients in advanced Maillard reaction 

by H. Odani, Y. Matsumoto, T. Shinzato, J. Usami and K. Maeda (Nagoya, Japan)

Pilot study of gas chromatographic-mass spectrometric screening of newborn urein for inborn errors of metabolism after treatment with urease

by T. Kuhara, T. Shinka,   Y. Inoue, M. Ohse and X. Zhen-wei (Ishikawa, Japan), I, Yoshida, T. Inokuchi  (Fukuoka, Japan), S. Yamaguchi (Shimane, Japan), M. Takayanagi (Chiba, Japan) and   I, Matsumoto (Ishikawa, Japan)

by T. Imamura (Hiroshima, Japan), K. Kudo (Fukuoka, Japan), A. Namera (Hiroshima, Japan), H. Tokunaga (Fukuoka, Japan), M. Yashiki (Hiroshima, Japan), N. Jitsufuchi (Fukuoka, Japan) and T. Kojima (Hiroshima, Japan)

by F. Guan, A. Ishi, H. Seno, K. Watanabe-Suzuki (Hamamatsu, Japan), T. Kumazawa           (Tokyo,Japan)  and O. Suzuki (Hamamatsu, Japan)